Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Multicentre randomised trial comparing contact force with electrical coupling index in atrial flutter ablation (VERISMART trial).

Begg GA, O'Neill J, Sohaib A, McLean A, Pepper CB, Graham LN, Hogarth AJ, Page SP, Gillott RG, Hill N, Walshaw J, Schilling RJ, Kanagaratnam P, Tayebjee MH.

PLoS One. 2019 Apr 3;14(4):e0212903. doi: 10.1371/journal.pone.0212903. eCollection 2019.

2.

Left atrial voltage, circulating biomarkers of fibrosis, and atrial fibrillation ablation. A prospective cohort study.

Begg GA, Karim R, Oesterlein T, Graham LN, Hogarth AJ, Page SP, Pepper CB, Rhode K, Lip GYH, Holden AV, Plein S, Tayebjee MH.

PLoS One. 2018 Jan 2;13(1):e0189936. doi: 10.1371/journal.pone.0189936. eCollection 2018.

3.

Intra-cardiac and peripheral levels of biochemical markers of fibrosis in patients undergoing catheter ablation for atrial fibrillation.

Begg GA, Karim R, Oesterlein T, Graham LN, Hogarth AJ, Page SP, Pepper CB, Rhode K, Lip GYH, Holden AV, Plein S, Tayebjee MH.

Europace. 2017 Dec 1;19(12):1944-1950. doi: 10.1093/europace/euw315.

4.

Effect of cellular and extracellular pathology assessed by T1 mapping on regional contractile function in hypertrophic cardiomyopathy.

Swoboda PP, McDiarmid AK, Erhayiem B, Law GR, Garg P, Broadbent DA, Ripley DP, Musa TA, Dobson LE, Foley JR, Fent GJ, Page SP, Greenwood JP, Plein S.

J Cardiovasc Magn Reson. 2017 Feb 20;19(1):16. doi: 10.1186/s12968-017-0334-x.

5.

Role of T1 Mapping in Inherited Cardiomyopathies.

Swoboda PP, McDiarmid AK, Page SP, Greenwood JP, Plein S.

Eur Cardiol. 2016 Winter;11(2):96-101. doi: 10.15420/ecr/2016:28:2.

6.

Early Repolarization Syndrome; Mechanistic Theories and Clinical Correlates.

Mercer BN, Begg GA, Page SP, Bennett CP, Tayebjee MH, Mahida S.

Front Physiol. 2016 Jun 30;7:266. doi: 10.3389/fphys.2016.00266. eCollection 2016. Review.

7.

Assessing Myocardial Extracellular Volume by T1 Mapping to Distinguish Hypertrophic Cardiomyopathy From Athlete's Heart.

Swoboda PP, McDiarmid AK, Erhayiem B, Broadbent DA, Dobson LE, Garg P, Ferguson C, Page SP, Greenwood JP, Plein S.

J Am Coll Cardiol. 2016 May 10;67(18):2189-2190. doi: 10.1016/j.jacc.2016.02.054. No abstract available.

8.

Evolution of Electrocardiographic and Structural Features Over 3 Decades in Arrhythmogenic Cardiomyopathy.

Abrams DJ, Kirkby C, Page SP, Earley MJ, Nitiou D, Kelsell DP, Schilling RJ.

Circulation. 2015 Jun 23;131(25):2233-5. doi: 10.1161/CIRCULATIONAHA.115.014371. No abstract available.

PMID:
26099957
9.

Ischemic ventricular tachycardia presenting as a narrow complex tachycardia.

Page SP, Watts T, Yeo WT, Mehul D.

Indian Pacing Electrophysiol J. 2014 Jul 15;14(4):203-10. eCollection 2014 Jul.

10.

Periprocedural stroke risk in patients undergoing catheter ablation for atrial fibrillation on uninterrupted warfarin.

Page SP, Herring N, Hunter RJ, Withycombe E, Lovell M, Wali G, Betts TR, Bashir Y, Dhinoja M, Earley MJ, Sporton SC, Rajappan K, Schilling RJ.

J Cardiovasc Electrophysiol. 2014 Jun;25(6):585-90. doi: 10.1111/jce.12411. Epub 2014 Apr 17.

PMID:
24641450
11.

A randomized controlled trial of catheter ablation versus medical treatment of atrial fibrillation in heart failure (the CAMTAF trial).

Hunter RJ, Berriman TJ, Diab I, Kamdar R, Richmond L, Baker V, Goromonzi F, Sawhney V, Duncan E, Page SP, Ullah W, Unsworth B, Mayet J, Dhinoja M, Earley MJ, Sporton S, Schilling RJ.

Circ Arrhythm Electrophysiol. 2014 Feb;7(1):31-8. doi: 10.1161/CIRCEP.113.000806. Epub 2014 Jan 1.

PMID:
24382410
12.

The Prevalence of Low Left Atrial Appendage Emptying Velocity and Thrombus in Patients Undergoing Catheter Ablation for Atrial Fibrillation on Uninterrupted Peri-procedural Warfarin Therapy.

Herring N, Page SP, Ahmed M, Burg MR, Hunter RJ, Earley MJ, Sporton SC, Newton JD, Sabharwal NK, Myerson SG, Bashir Y, Betts TR, Schilling RJ, Rajappan K.

J Atr Fibrillation. 2013 Apr 6;5(6):761. doi: 10.4022/jafib.761. eCollection 2013 Apr-May.

13.

Epicardial catheter ablation for ventricular tachycardia in heparinized patients.

Page SP, Duncan ER, Thomas G, Ginks MR, Earley MJ, Sporton SC, Dhinoja M, Schilling RJ.

Europace. 2013 Feb;15(2):284-9. doi: 10.1093/europace/eus258. Epub 2012 Sep 21.

PMID:
23002196
14.

A novel Myosin essential light chain mutation causes hypertrophic cardiomyopathy with late onset and low expressivity.

Andersen PS, Hedley PL, Page SP, Syrris P, Moolman-Smook JC, McKenna WJ, Elliott PM, Christiansen M.

Biochem Res Int. 2012;2012:685108. doi: 10.1155/2012/685108. Epub 2012 Apr 11.

15.

SmartTouch™ - The Emerging Role of Contact Force Technology in Complex Catheter Ablation.

Page SP, Dhinoja M.

Arrhythm Electrophysiol Rev. 2012 Sep;1(1):59-62. doi: 10.15420/aer.2012.1.1.59.

16.

Chest pain and ST elevation.

Page SP, Archbold A, Abrams DJ.

BMJ. 2012 Jun 27;344:e4323. doi: 10.1136/bmj.e4323. No abstract available.

PMID:
22740569
17.

Improved electrogram attenuation during ablation of paroxysmal atrial fibrillation with the Hansen robotic system.

Duncan ER, Finlay M, Page SP, Hunter R, Goromonzi F, Richmond L, Baker V, Ginks M, Ezzat V, Dhinoja M, Earley MJ, Sporton S, Schilling RJ.

Pacing Clin Electrophysiol. 2012 Jun;35(6):730-8. doi: 10.1111/j.1540-8159.2012.03381.x. Epub 2012 Apr 11.

PMID:
22494451
18.

Cardiac myosin binding protein-C mutations in families with hypertrophic cardiomyopathy: disease expression in relation to age, gender, and long term outcome.

Page SP, Kounas S, Syrris P, Christiansen M, Frank-Hansen R, Andersen PS, Elliott PM, McKenna WJ.

Circ Cardiovasc Genet. 2012 Apr 1;5(2):156-66. doi: 10.1161/CIRCGENETICS.111.960831. Epub 2012 Jan 20.

PMID:
22267749
19.

Dual ventricular response: what is the mechanism?

Page SP, Pfeffer C, Schilling RJ, Sporton SC.

J Cardiovasc Electrophysiol. 2012 Jun;23(6):669-71. doi: 10.1111/j.1540-8167.2011.02174.x. Epub 2011 Sep 28. No abstract available.

PMID:
21954989
20.

Maintenance of sinus rhythm with an ablation strategy in patients with atrial fibrillation is associated with a lower risk of stroke and death.

Hunter RJ, McCready J, Diab I, Page SP, Finlay M, Richmond L, French A, Earley MJ, Sporton S, Jones M, Joseph JP, Bashir Y, Betts TR, Thomas G, Staniforth A, Lee G, Kistler P, Rajappan K, Chow A, Schilling RJ.

Heart. 2012 Jan;98(1):48-53. doi: 10.1136/heartjnl-2011-300720. Epub 2011 Sep 19.

PMID:
21930724
21.

Catheter ablation for atrial fibrillation on uninterrupted warfarin: can it be done without echo guidance?

Page SP, Siddiqui MS, Finlay M, Hunter RJ, Abrams DJ, Dhinoja M, Earley MJ, Sporton SC, Schilling RJ.

J Cardiovasc Electrophysiol. 2011 Mar;22(3):265-70. doi: 10.1111/j.1540-8167.2010.01910.x. Epub 2010 Oct 6.

PMID:
21040095
22.

Long-term benefits of pacing in obstructive hypertrophic cardiomyopathy.

Mohiddin SA, Page SP.

Heart. 2010 Mar;96(5):328-30. doi: 10.1136/hrt.2009.173765. Epub 2009 Nov 23. No abstract available.

PMID:
19934102
23.

Micro-exons of the cardiac myosin binding protein C gene: flanking introns contain a disproportionately large number of hypertrophic cardiomyopathy mutations.

Frank-Hansen R, Page SP, Syrris P, McKenna WJ, Christiansen M, Andersen PS.

Eur J Hum Genet. 2008 Sep;16(9):1062-9. doi: 10.1038/ejhg.2008.52. Epub 2008 Mar 12.

24.

Prevalence of exercise-induced left ventricular outflow tract obstruction in symptomatic patients with non-obstructive hypertrophic cardiomyopathy.

Shah JS, Esteban MT, Thaman R, Sharma R, Mist B, Pantazis A, Ward D, Kohli SK, Page SP, Demetrescu C, Sevdalis E, Keren A, Pellerin D, McKenna WJ, Elliott PM.

Heart. 2008 Oct;94(10):1288-94. Epub 2007 Nov 21.

PMID:
18032461
25.
26.

Incidence, duration and causes of intensive care unit admission following pulmonary resection for malignancy.

Melley DD, Thomson EM, Page SP, Ladas G, Cordingley J, Evans TW.

Intensive Care Med. 2006 Sep;32(9):1419-22. Epub 2006 Jul 7.

PMID:
16826388

Supplemental Content

Support Center